Cancer Care Ontario | Cancer Care Ontario

9 Results

Guidelines and Advice

Referral of Suspected Lung Cancer by Primary Care Practitioners

Status: Current
ID: 24-2
Version: 2

Jan 2019

Guidelines and Advice

Routine Human Papilloma Virus (HPV) Testing in Squamous Cell Head and Neck Cancer

Status: Current
ID: 5-9
Version: 2

Jan 2020

Guidelines and Advice

Risk Reduction Strategies for BRCA1/2 Hereditary Ovarian Cancer Syndromes

Status: Current
ID: GL #4-4v2
Version: 2

Sep 2020

Guidelines and Advice

Recommendations for Prophylactic Cranial Irradiation and Consolidative Radiation for Patients with Small Cell Lung Cancer: Endorsement of the 2019 National Institute for Health and Care Excellence Guidance

Status: In-Review
ID: GL END 7-13-2
Version: 2

Nov 2019

Guidelines and Advice

Recommendations for the Treatment of Patients with Clinical Stage III Non-Small Cell Lung Cancer: Endorsement of the 2019 National Institute for Health and Care Excellence Guidance and the 2018 Society for Immunotherapy of Cancer Guidance

Status: In-Review
ID: GL END 7-3
Version: 4

Apr 2020

Regimen

RITU(IT)

Cancer Type:

Hematologic,

Leukemia - Acute Lymphoblastic (ALL),

Lymphoma - Non-Hodgkin's High Grade,

Lymphoma - Non-Hodgkin's Intermediate Grade

Show More Show more tags

, Show Less Show fewer tags

Intent: Curative

Drugs Used:

riTUXimab (Unfunded)

... Show more tags

, Collapse Show fewer tags

Quick Link(s):

Regimen Monograph

Aug 2020

Drug

radium-223

Other Name(s): Xofigo®

Quick Link(s):

Drug Monograph

Jun 2019

Guidelines and Advice

Regional Models of Care for Systemic Treatment: Standards for the Organization and Delivery of Systemic Treatment

Status: Current
ID: GL 12-10
Version: 2

Jul 2019

Guidelines and Advice

Regional Therapies for Colorectal Cancer Liver Metastases

Status: Current
ID: GL 2-30a
Version: N/A

Mar 2020